David Beauvais

19PUBLICATIONS
79CO-AUTHORS
Respiratory diseasesGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Sara Villar, Sylvie Chevret, Xavier Poire

|Nov 09, 2022
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients.

Mathilde Sourisseau, Emmanuel Faure, Hélène Béhal

|Sep 22, 2022
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi

|Sep 19, 2022
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.

Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy

|Mar 30, 2022
Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.

Kevin-James Wattebled, Elodie Drumez, Valérie Coiteux

|Jan 12, 2022
Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.

Rémi Tilmont, Ibrahim Yakoub-Agha, Nassima Ramdane

Pageof 4

Frequent Collaborators

4 joint publications

Patrice Chevallier

3 joint publications

Michaël Loschi

3 joint publications

Edouard Forcade

3 joint publications

Xavier Poiré